Palliative Treatment of Malignant Ascites: Profile of Catumaxomab

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s6697
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited